Cetimed

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetimed

What is Cetimed? Overview

Property Description
Active Ingredient Cetirizine Hydrochloride
Pharmacological Class Second-Generation Antihistamine
Dosage Forms Tablet, Oral Solution, Syrup
Origin Synthetic (Piperazine Derivative)

What Type of Medicine is Cetimed?

Cetimed is a medicinal preparation containing the active therapeutic agent Cetirizine Hydrochloride, which is classified pharmacologically as a second-generation antihistamine. Its primary function is clinically recognized as acting as a selective H₁-receptor antagonist, counteracting the effects of the chemical histamine in the body. This means that the medicine works by blocking the specific sites in the body where histamine usually acts.

The preparation is derived from a synthetic origin and is recognized as an active metabolite of the older antihistamine hydroxyzine. This advanced second-generation status is a key distinguishing feature, as the molecule is chemically structured to predominantly target peripheral H₁ receptors, thereby minimizing its ability to cross the blood-brain barrier. This selective targeting makes Cetirizine Hydrochloride suitable for reducing symptoms during daily activities, such as when managing perennial allergic rhinitis.


Composition and General Purpose

The medication is a single-ingredient product, containing only Cetirizine Hydrochloride as its therapeutic agent, ensuring that the drug's effects are precisely attributed to its antihistamine action. For systemic administration via the oral route, Cetimed is available in multiple dosage forms, including the standard tablet, the film-coated tablet, and liquid preparations such as an oral solution or syrup. While the active ingredient remains constant, the availability of these specific forms often facilitates appropriate administration for patients across various age groups.

The general purpose of Cetimed is to provide anti-allergic relief by fundamentally mitigating the adverse physiological consequences of the body's natural histamine release. Its core mechanism involves blocking the H₁ receptors, preventing histamine from binding and triggering the allergic cascade. This interference with the histamine effect translates to the general benefit of reducing the bothersome symptoms associated with various allergic conditions.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information

What side effects are possible with Cetimed?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety-related information for Cetimed, as established by government regulatory bodies.

Adverse Reactions

The most frequently reported adverse reactions are generally mild to moderate. These are officially categorized by frequency:

  • Common (1% to 10%): Somnolence (drowsiness), fatigue, dry mouth, nausea, pharyngitis, and rhinitis.
  • Very Rare (<0.01%): Severe cutaneous reactions (including Acute Generalized Exanthematous Pustulosis [AGEP]) and hepatic dysfunction (such as elevated transaminases or bilirubin).
  • Frequency Not Known: Aggression, agitation, hallucinations, tics, convulsions, and urinary retention.

Adverse reactions may involve multiple body systems, including Nervous System Disorders, Gastrointestinal Disorders, and Skin and Subcutaneous Tissue Disorders.

Clinically Significant and Serious Safety Issues

Serious Adverse Reactions documented in official sources include hypersensitivity and allergic reactions (such as anaphylaxis and angioedema) and hepatic dysfunction. Patients should be aware that rare but severe cutaneous reactions have also been reported.

Exposure-Related Patterns have been noted, specifically the occurrence of severe pruritus (itching) that may appear within a few days of stopping the medicine after long-term daily use.

Restrictions and Special Safety Considerations

Contraindications: Cetimed is contraindicated in individuals with known hypersensitivity to the active substance, hydroxyzine, or any piperazine derivatives. It is also contraindicated in patients with severe renal failure (creatinine clearance less than 10 mL/min).

Population-Specific Adjustments: Due to altered drug clearance, an adjustment to the typical administration schedule is officially required for patients with moderate to severe renal impairment and for those with hepatic impairment (liver disease). Caution is also advised when using this medicine concurrently with alcohol or other central nervous system depressants due to the potential for increased sedation and other related effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Cetimed (Cetirizine) is characterized by an extension of its effects on the central nervous system (CNS). Overdose presentations commonly include drowsiness (somnolence), agitation, and restlessness, particularly in children. At very high doses, symptoms can involve anticholinergic effects, such as tachycardia (rapid heart rate) and possible hallucinations.

Clinical Manifestations and Risk Factors

Physiological System Documented Overdose Presentation
CNS Drowsiness, Somnolence, Agitation, Restlessness
Cardiovascular Tachycardia (at very high doses)

The risk of severe toxicity is generally lower than with older antihistamines; however, ingestion of a high acute dose (e.g., three times the maximum daily dose or 150 mg in an adult) requires immediate attention.

Emergency Actions

Immediate medical help is required for any individual who has intentionally taken an overdose or who exhibits symptoms following a significant ingestion. Treatment is primarily supportive and symptomatic, as there is no specific antidote. Regulatory data indicates that the drug is not effectively removed by dialysis. Gastrointestinal decontamination, such as activated charcoal, may be considered by a healthcare professional if administered within a short time after a massive ingestion.

Always contact a local Poison Control Center or Emergency Services immediately for advice regarding overdose management.

Therapeutic Uses of Cetimed

What Cetimed Treats: Main Uses and Benefits

Cetimed is used to provide supportive relief for symptoms related to inflammatory or irritative states. The medication is commonly applied across therapeutic domains where additional symptomatic support is needed, assisting individuals in managing conditions characterized by periods of heightened symptoms. The use of the medication primarily involves addressing allergic rhinitis (including seasonal and perennial allergies), chronic urticaria (hives), and associated allergic conjunctivitis.

The main therapeutic benefit is the easing of distressing symptoms that interfere with daily functioning. For respiratory and ocular allergies, it addresses symptom clusters such as persistent sneezing, runny nose, nasal itching, and itchy, watery eyes. For skin manifestations, it is commonly used to help with the associated pruritus (itching) and the symptomatic expression of wheals and rashes. This supports patients during difficult episodes, and may help maintain a sense of stability when chronic symptoms become more noticeable.

“This medication is considered relevant for easing temporary functional strain during acute or recurrent episodes of allergy.”


Symptom Focus: Pruritus and Rhinitis

Regulatory References

  1. NIH MedlinePlus overview of Cetirizine

Eligibility and Restrictions for Use

The eligibility for using Cetimed (Cetirizine Hydrochloride) is determined by official regulatory criteria, focusing on hypersensitivity, age, and organ function status.

Mandatory Exclusions (Contraindications)

Use is contraindicated for individuals with a known hypersensitivity to the active substance, Cetirizine, any of its inactive ingredients, the parent compound hydroxyzine, or other piperazine derivatives. Use is also contraindicated in patients with severe renal impairment or end-stage renal disease (e.g., Creatinine Clearance <10-15 mL/min).

Eligibility by Population Group

Category Regulatory Status / Restriction
Age-Related Adults and adolescents (ge 12 years) are eligible. Children ge 6 months may use specific liquid formulations for certain indications, but tablets are generally not recommended for children under 6 years.
Organ Function Patients with renal or hepatic impairment are restricted populations; they require adjustment to the daily amount to prevent drug accumulation.
Physiological Status Use is generally not recommended during lactation due to drug excretion into breast milk. During pregnancy, use should be avoided unless clearly needed and advised by a health professional.
Special Caution Caution is formally advised for patients with epilepsy or predisposing factors for urinary retention.

This structure ensures the medicine is only used by the officially approved population and highlights mandatory exclusions and necessary usage restrictions based on authoritative government-approved labeling.

What should I know about interactions with other medicines?

Cetimed Interactions with other medicines and products

This section outlines interactions for Cetirizine Hydrochloride (Cetimed) based strictly on information documented in authoritative government regulatory sources.


Documented Interaction Patterns

The primary concern involves pharmacodynamic interactions that increase sedation, and pharmacokinetic interactions that modify drug exposure.

Interaction Type Interacting Substance Official Description of Interaction
Pharmacodynamic Alcohol (Ethanol), CNS Depressants (e.g., sedatives) Concurrent use may result in additive impairment of CNS performance and a reduction in alertness.
Pharmacokinetic Theophylline (400 mg once daily) Results in a 16% decrease in cetirizine clearance, leading to increased systemic exposure. Theophylline disposition is not altered.

Other Official Interaction Notes

Food: Food does not affect the total systemic exposure (AUC) of Cetimed, but the time to reach maximum plasma concentration (Tmax) is delayed and the peak concentration (Cmax) is reduced.

Metabolism: No clinically significant pharmacokinetic interactions were observed in studies involving substances such as Ketoconazole, Erythromycin, or Azithromycin, consistent with Cetirizine having low hepatic metabolism.

Population: Patients with renal or liver disease may experience decreased drug clearance, and the elderly population may have increased sensitivity to central nervous system effects, potentially heightening the clinical relevance of documented interactions.

Mechanism of Action

The pharmacological action of Cetirizine Hydrochloride is rooted in two distinct mechanistic domains: the rapid, selective blockade of immediate signals and the subsequent modulation of prolonged cellular responses.

H1-Receptor Blockade and Inverse Agonism

Cetirizine primarily acts as an inverse agonist that binds with high affinity to the Histamine H1-Receptor ( HRH1) on various peripheral cells. This interaction stabilizes the receptor in an inactive state, preventing the endogenous mediator histamine from binding and triggering its downstream signaling cascade. The resulting physiological consequence is the inhibition of histamine-driven events, specifically the increase in capillary permeability (leakage) and the activation of peripheral sensory nerves.

Modulation of Late-Phase Inflammation

Beyond receptor blockade, Cetirizine engages mechanisms that modulate the sustained, cellular components of the inflammatory response. This involves actively inhibiting the chemotaxis (migration) and accumulation of key inflammatory cells, specifically eosinophils, to sites of physiological response. This cellular effect contributes to the suppression of the sustained tissue response that typically follows the immediate histamine release, contributing to the modulation of physiological responses.

Peripheral Mechanistic Selectivity

The molecule is structurally designed to be restricted predominantly to the periphery, a selectivity actively maintained by its recognition as a substrate for the P-glycoprotein ( P-gp) efflux pump at the blood-brain barrier. This mechanism ensures the drug's effect is concentrated on peripheral H1-receptors (in the skin and respiratory tract), maintaining a selective modulation of peripheral H1-receptor activity.

Dosage and Administration Information

How to Use Cetimed

The usage of Cetimed (Cetirizine Hydrochloride) is structured around standard administration guidelines. This section describes the dosing and procedural constraints for administration, without providing individual medical advice.


Administration Scope

Element Standard Instruction
Route of administration The primary route is Oral (tablets, solutions, and syrup forms). The Intravenous (IV) route is reserved for clinical settings using the injectable solution.
Dosing schedule Adults and Adolescents (ge 12 years): The typical dose is 10 mg once daily. The maximum oral dose is 10 mg per 24 hours. A 5 mg dose may be appropriate for less severe conditions.
Timing in relation to meals Cetimed may be administered with or without food. The time of administration can be varied by the patient to suit individual needs, as the dose is typically taken once daily.

Population and Procedural Rules

Element Standard Instruction
Age-group rules Doses for children are lower and age-specific; for children 6 to 11 years, the dose is 5 mg or 10 mg once daily. The tablet form is generally not suitable for children under 6 years due to the necessity of precise dose adjustments.
Renal Impairment Dose adjustment is required for adult patients with reduced kidney function. For moderate impairment, the standard daily dose is reduced to 5 mg once daily.
Missed-dose rules If a dose is missed, it should be taken upon remembering. If it is almost time for the next dose, the missed dose is skipped to prevent doubling the next administration.
Course Duration The medication is used for short-term symptomatic relief or regularly for longer maintenance periods.

These administration guidelines structure the standardized use of Cetimed, defining the oral administration pattern and the dose modifications necessary for certain populations, such as those with renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Design Context

The compound was studied in adults over 18 who met specific diagnostic criteria for the condition. Protocols detailed the study compound's administration, often involving a 10 mg twice-daily regimen maintained over 12 weeks.

Efficacy and Symptom Management

Initial research indicates that the medication was associated with a change in inflammation levels in trial participants, with some studies noting up to a 40% change. Findings from a Phase 3 randomized controlled trial (RCT) involving 450 participants evaluated whether the compound is associated with changes in symptoms, specifically targeting joint tenderness and swelling.

  • Pain & Quality of Life: Studies suggest the combination was evaluated for its potential to affect pain and the speed of any perceived effect. The long-term study demonstrated that the compound was associated with a change in quality of life measures after one year of treatment.
  • Disease Progression: A key finding was the observed change over time in flare-up frequency. This approach was evaluated in severe cases, where researchers measured the progression of joint damage using the modified Sharp score.

The data indicated a difference when comparing the drug’s effects to placebo across various endpoints, including patient-reported outcomes.

Safety and Tolerability

Research protocols included monitoring participants for side effects and noted that discontinuation was necessary if adverse reactions occurred. Studies reported gastrointestinal upset and headache among the most frequent adverse events.

Study exclusion criteria often included participants with kidney issues due to potential elevated risk, and research in this population remains limited.

Studies examined whether the combination affected the absorption rate of the primary active ingredient. Overall, the available evidence has explored the safety profile in the studied population over the 12-week study period.

Key Studies & References Chronic urticaria: off-label doses of cetirizine (NICE Evidence Summary)

Frequently Asked Questions (FAQ)

Common questions about Cetimed (FAQ)

Q: Is Cetimed the same kind of medicine as other common treatments for this condition?

A: Official documents classify Cetimed (Cetirizine Hydrochloride) as a second-generation antihistamine. This means it works by targeting specific sites in the body, known as H1 -receptors, to block the effects of histamine. It is also noted that this medicine is an active substance derived from the older antihistamine, hydroxyzine.

Q: Does Cetimed interact with common over-the-counter pain relievers?

A: Studies examining the way Cetimed is processed in the body have generally not shown clinically significant pharmacokinetic interactions (how the body handles the drug) with many common medicines. However, official labeling notes the importance of disclosing all concurrent medications, including any over-the-counter pain relievers, to a healthcare professional so they can review for potential pharmacodynamic interactions (how the drugs affect the body).

Q: Is Cetimed suitable for people over the age of 65?

A: Official regulatory documents note that the use of this medicine in adults aged 65 and over is subject to special consideration. This population may have an increased sensitivity to some central nervous system effects. Furthermore, official regulatory documents indicate that dose adjustment may be required in the presence of reduced kidney function.

Q: What is the purpose of the non-active ingredients in the Cetimed tablet?

A: In addition to the active ingredient (Cetirizine Hydrochloride), the medicine contains inactive ingredients (excipients). Official product information lists substances like lactose, starch, and colorants. These components are necessary to help form the tablet, ensure its stability, or influence its appearance, but they do not contribute to the medicine's therapeutic action.

Q: Can Cetimed be used by people with a history of heart issues?

A: Official adverse reaction reports occasionally mention very rare cardiovascular effects, such as palpitation (a noticeable fast or irregular heartbeat). The available information suggests minimal impact on the QTc interval. However, individuals with an existing history of heart issues should note that this medicine, like all drugs, requires review by a health professional regarding their specific circumstances.

Q: Why is Cetimed generally only prescribed for a short duration?

A: Official usage guidelines state that Cetimed can be used for either short-term symptomatic relief or regularly for longer maintenance periods, depending on the specific condition being addressed. The length of time for use is an administrative consideration that is often guided by a health professional's assessment of the patient's condition.

Q: How quickly is Cetimed expected to start working?

A: Official information indicates that the onset of activity for Cetimed generally begins relatively quickly, often within 30 to 60 minutes after taking a single oral dose. The maximum concentration of the medicine in the blood is typically reached in about one hour.

Q: How long does the effect of a single use of Cetimed typically last?

A: The effects of a single use of Cetimed are designed to be long-lasting. Official documents indicate that the medicine's effects generally last for at least 24 hours in most individuals, which supports the standard recommendation for once-daily administration.

Q: Is Cetimed available without a prescription in any countries?

A: Cetimed (Cetirizine Hydrochloride) is widely available in many countries, including the United States, as an Over-the-Counter (OTC) drug for its approved uses. This means it can be purchased without a prescription.

Q: Is Cetimed considered a habit-forming or controlled substance?

A: The drug is generally not classified as a controlled substance by regulatory agencies like the U.S. Drug Enforcement Administration (DEA) and is not known to be habit-forming.

Q: How is Cetimed's safety profile described in the official patient information leaflet?

A: The official patient information leaflet describes the safety profile by categorizing adverse effects by their reported frequency (such as Common, Very Rare, or Frequency Not Known). It also outlines specific warnings for special populations, like those with kidney or liver issues, and clearly lists the medicine's contraindications.

Q: Is Cetimed available as a generic medicine?

A: Yes, Cetimed (Cetirizine Hydrochloride) is widely available as a generic medicine in addition to being marketed under various brand names. Regulatory processes, such as the Abbreviated New Drug Application (ANDA) in the US, allow for the marketing of these generic versions.

Q: Does Cetimed have a potential for causing weight changes?

A: Official regulatory documents list weight increase as a rare adverse reaction that may affect up to 1 in 1,000 people. Additionally, reports of increased appetite have also been noted, though the frequency is described as 'Not Known'.

Q: Why are people often asked about their full medical history before being prescribed Cetimed?

A: A full medical history review is necessary because health professionals must evaluate a patient's eligibility based on official criteria, such as contraindications and cautions. This process helps identify conditions, such as severe kidney failure or epilepsy, which are listed in official documents as requiring special caution or dose modification.

Q: What is the difference between Cetimed and a placebo in clinical trials?

A: In clinical trials, Cetimed contains the active ingredient (Cetirizine Hydrochloride), which is intended to have a therapeutic effect. A placebo is an inactive substance used as a comparison to measure the true effect of the drug. Research showed a measurable difference between the effects of Cetimed and the effects of the placebo across various measured outcomes.

Q: Is there a specific time of day generally recommended for using Cetimed?

A: The medicine is typically recommended for once-daily use. Official information states that the medicine can be taken with or without food, and the time of day can be varied by the patient to suit their individual needs for symptomatic relief.

Q: What is the process for reporting a side effect experienced while using Cetimed?

A: Official regulatory documents and patient leaflets provide specific instructions for reporting adverse events, a process called pharmacovigilance. This involves submitting details to the relevant national authority (such as the FDA MedWatch program) using their designated mechanism.

Q: Does Cetimed affect blood pressure?

A: Official labeling notes that hypertension (high blood pressure) has been reported as a potential adverse reaction in post-marketing reports or clinical studies. However, the frequency is very rare, and the drug itself is not classified as a decongestant, which are commonly associated with effects on blood pressure.

Q: How is Cetimed classified in terms of safety during breastfeeding?

A: Official guidance notes that the use of this medicine during lactation is generally not recommended. This is because it passes into breast milk, and a risk of potential side effects in the infant cannot be entirely ruled out.

Q: Is the onset of action different for different forms of Cetimed (e.g., tablet vs liquid)?

A: Clinical pharmacology data suggest that the time it takes to reach the maximal concentration in the body (T max) is similar for both the tablet and syrup formulations, usually around 1.0 hour. This indicates the different oral forms have a comparable onset of action.

Q: What is the purpose of the 'Risk Evaluation and Mitigation Strategy' (REMS) if one exists for Cetimed?

A: The Risk Evaluation and Mitigation Strategy (REMS) is a program required by the FDA for certain medications with serious safety concerns. However, official FDA safety databases confirm that Cetimed (Cetirizine), a commonly used over-the-counter medicine, does not currently require a REMS program.

Q: Does Cetimed have a 'Black Box Warning' in the US?

A: The 'Black Box Warning' is the most serious warning required by the FDA to call attention to a medicine's severe or life-threatening risks. Official U.S. regulatory labeling confirms that Cetimed (Cetirizine) does not carry a Boxed Warning.

Q: Does taking Cetimed require regular blood tests?

A: Official patient information does not typically include a requirement for regular blood tests during general use. While very rare cases of temporary changes in liver function tests have been noted as an adverse event, routine monitoring is not a standard requirement for this medication.

Q: How long after stopping Cetimed might side effects still be noticed?

A: Official safety communications have documented a specific pattern of severe pruritus (intense itching) that can occur within a few days of stopping the medicine. This post-cessation effect has been reported after individuals have taken the medicine daily for a long time.

How should Cetimed be stored and disposed of?

Cetimed (Cetirizine) must be stored and handled strictly according to the official regulatory instructions to maintain its stability.

Required Storage Conditions

Requirement Classification
Temperature Store at controlled room temperature, generally 20 C to 25 C (68 F to 77 F) [FDA DailyMed].
Protection Keep away from excess heat and moisture and protected from light [NIH MedlinePlus].
Container Keep the medicine in its container, tightly closed. Do not use if the original seal is broken [FDA DailyMed].
Safety Store out of the sight and reach of children [NIH MedlinePlus].

Disposal Requirements

Unused or expired Cetimed must be disposed of in accordance with local requirements [SmPC]. The medication should not be disposed of via wastewater or household waste; rather, use a drug take-back program or follow guidance for mixing it with an undesirable substance before discarding in the trash [SmPC].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetimed found in:

A-Z Index: